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Abstract
Background: Ethiopia has had mechanisms for TB/HIV collaborative activities since 2002. However, no published
account has defined the role of these collaborative efforts in strengthening linkages between HIV and TB
management units at the point-of-care level. Our objective was to assess the extent of linkages between the two
programs at the patient management level at Zewditu Memorial Hospital in Addis Ababa, Ethiopia. Between
January and December 2008, the registers of 241 TB patients were reviewed to determine the HIV testing rate, the
treatment charts of 238 randomly selected patients were reviewed for providers’ compliance with evaluation
criteria, and exit interviews were conducted with 309 TB/HIV co-infected clients to validate providers’ compliance.
Results: From register review, it was determined that the HIV testing acceptance rate was 95%, and that 70% of
patients received post-test counseling. A review of the patient chart revealed that of 51 patients with a complaint
of cough, duration for cough was recorded in 35 (68.6%) cases and cough > 2 weeks was recorded in 25 (49.0%)
cases. Seventy two percent (18 of 25) were linked for sputum microscopy. Linkage to cotrimoxazole prophylactic
treatment was 81%, but only 47% of eligible patients were linked to isoniazid preventive therapy (IPT). Correct
diagnosis was accomplished at a rate of 100% for smear positive pulmonary TB, 23% for smear negative pulmonary
TB and 88% for extra pulmonary TB patients. Both chart review and exit interviews indicated that history of TB
contact and cough > 2 weeks predicted TB disease.
Conclusion: The rates of HIV testing and linkage to cotrimoxazole prophylactic therapy were high. Improvement is
needed in the areas of recording patient information, screening HIV positives for TB, initiation of IPT, referral,
linkages, and TB diagnostic capacity.
Background
Tuberculosis (TB) is the leading killer of human immu-
nodeficiency virus (HIV) infected individuals, and the
overlapping epidemics have had a devastating impact on
TB and HIV morbidity, mortality and control worldwide
[1]. These TB and HIV co-epidemics require urgent and
effective attention and demand a collaborative effort
between TB and HIV programs employing different but
complementary strategies. Both programs should be able
to identify and manage both diseases [2,3].
However, the two programs are often separate at the
level of patient care contributing to delayed diagnosis
and linkage to care. TB and HIV programs must estab-
lish linkages to better utilize resources, avoid missed
opportunities, and accelerate universal access to
comprehensive TB and HIV prevention, treatment and
care services [4].
In Ethiopia, 24% HIV sero prevalence is reported in
TB patients from health facilities implementing TB/HIV
services [5]. In 2000, of 51 consecutive cultures of pro-
ven TB patients in Addis Ababa, 47% were HIV Positive
[6]. Nonetheless, no research in Ethiopia defined the
collaborative activities since it started implementation in
2002. The objective of this study was to describe the
level of linkage between TB and HIV programs in
patients attending care and treatment in Zewditu Mem-
orial Hospital in Addis Ababa.
Methods
Study setting
Zewditu Memorial Hospital (ZMH) is a general hospital
located in Addis Ababa, Ethiopia. It has been providing
antiretroviral therapy since 2003. Addis Ababa has a
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any medium, provided the original work is properly cited.projected population of 3 million, and is divided in to 10
administrative sub cities and 99 localities [7,8].
As a standard of care, the Ethiopian national guide-
lines for TB/HIV collaboration advised offering HIV
testing to those with cough > 2 weeks, provision of IPT
to HIV positives screened negative for TB, cotrimoxa-
zole prophylactic therapy (CPT) to co- infected patients,
and regular TB screening of clients in HIV care [5].
Study design and data collection
This cross-sectional study was conducted between January
and December 2008. Three methods were used to evaluate
the performance of the TB/HIV collaborative activities:
review of registers of TB patients to determine the HIV
testing rate, retrospective review of charts of patients co-
infected with TB and HIV, and exit interviews. The regis-
ters of all the 241 TB patients who visited the clinic
between January and December 2008 were reviewed, as
well as the charts of 238 randomly selected TB/HIV co-
infected patients aged 18 years and above and treated at
the ZMH during the specified period. In addition, 309 ran-
domly selected TB/HIV co-infected patients were inter-
viewed during the data collection period.
Information was retrieved from TB and provider-
initiated counseling and testing (PICT) registers and
from HIV care/anti-retroviral treatment (ART) charts
using a data abstraction checklist. Data from registers
and charts included information on HIV testing and
post test counseling of TB patients, referral to HIV care
of HIV positive TB patients, screening of HIV positives
for (cough, fever, and night sweating > 2 weeks), weight
lost > 3 kg in the past 4 months, and history of TB con-
tact in the past 1 year, sputum microscopy for acid-fast
bacilli (AFB), sputum culture, lymph node fine needle
aspiration (FNA) test, linkage to IPT and CPT. Struc-
tured questionnaire containing standard TB screening
criteria(if the client had cough, fever, and night sweats
for > 2 weeks, weight loss > 3 kg in the last 4 weeks,
and TB contact in the past 1 year) were used for exit
interview of clients how they screened for TB. The
groups of patients included in the exit interview were
those screened for TB in the past 1 year.
The data abstraction checklist and the exit interview
questionnaire were adapted from the national TB/HIV
guideline [5], and pretested before being applied for data
collection. The questionnaire for exit interview was trans-
lated to Amharic (local language) and translated in English
to maintain consistency. We used experienced and trained
data collectors for all data collections activities.
Evaluation criteria
The following indicators adapted from World Health
Organization (WHO) guidelines were used to evaluate
the level of linkage implemented between TB and HIV
services: TB patients who are tested for HIV, HIV posi-
tive clients given IPT, co infected patients put on CPT,
proportion of patients with cough > 2 weeks duration
and sputum for AFB is ordered, proportions of TB sus-
pect patients diagnosed correctly for TB [5,9].
TB screening of HIV positives included asking ques-
tions based on a combination of symptoms of the five
TB screening criteria indicated in the national protocol.
The screening checklist included cough, fever, night
sweats (> 2 weeks), weight loss > 3 kg in the last 4
weeks, and history of TB contact in the past 1 year. If
the client said yes for cough > 2 weeks or if no to
cough > 2 weeks but yes to two or more of the other
questions the patient was further evaluated [5].
Diagnosis of TB in HIV positive patients was based on
the national TB/HIV guidelines. Pulmonary TB (PTB)
diagnosis was established if at least one sputum smear-
positive for AFB was detected. The algorithm for smear
negative PTB diagnosis required at least 2 slides negative
for sputum AFB, no response to broad spectrum antibio-
tic for 10-14 days, and radiographic abnormalities consis-
tent with active TB; or, at least 2 slides negative for
sputum AFB plus sputum culture positive for M. tuber-
culosis. Extra pulmonary TB (EPTB) diagnosis was based
on FNA suggestive of, or consistent with, active extra
pulmonary TB, one specimen from an extra pulmonary
site culture positive for M.tuberculosis, or smear positive
for AFB with the clinician’s decision to treat the patient
with a full course of anti-tuberculosis treatment.
Statistical analysis
Quantitative data was sorted, cleaned, and coded after
double data entry using the EPI-Info version 3.3.2 data
entry program. Analysis was conducted with SPSS 16.0
(SPSS inc. Chicago, 2007). Quantitative data was ana-
lyzed by calculating percentage of indicators using
descriptive statistics. Percentages were used for compari-
son. We used both bivariate and multivariate analysis to
estimate demographic characteristics and TB screening
criteria for specific outcome variables in the program.
We determined the level of significance at P < 0.05.
Ethical review
The study was approved by the ethics committee of
Addis Ababa Regional Health Bureau. The purpose of
exit interview was described and participation was fully
voluntary and all study subjects gave verbal consent.
Interview was done privately and data captured from
various sources were kept confidentially.
Results
HIV testing among TB patients
The mean age of registered TB patients was 30.2 years
[range 18-80 years; standard deviation (SD) 12.9]. Of
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(68/79) of those tested positive received post-test coun-
seling, 6% did not receive post-test counseling, and in
about 8% the status of post-test counseling was missing
(Table 1).
Medical chart reviews for provider compliance
Mean age of patients whose charts were reviewed was
34.6 years (range 18-60; SD 8.1). With respect to educa-
tional attainment, 42.8% had completed primary school
and 57.1% had completed secondary and above. About
46.2% were unemployed.
From 106 patients on ART and 132 patients on pre-
ART category included in the study, 44(41.5%) and 89
(67.4%) of patients were diagnosed for any form of TB
respectively. Two hundred and four (85.7%) patients
were asked for a history of cough. Fifty-one patients
(25.0%) had complaint of cough and duration of cough
was recorded for 35(68.6%). Cough lasting > 2 weeks
was recorded for 25(49.0%) of patients and 18(72.0%)
were linked for investigation of sputum for AFB. The
rate of sputum AFB positive for cough lasting > 2 weeks
was 29.6% with at least one slide positive for AFB. Of all
the charts with diagnosis of TB, 27(11.3%) were diag-
nosed for PTB, 65 (27.3%) smear negative PTB, and 41
(17.2%) were diagnosed for EPTB (Figure 1).
By chart review, one hundred and sixty three patients
were symptom screen positive for fever and history of
TB contact during the past year. Among these, 4(2.5%),
65 (39.9%), and 94(53.3), were not linked for radio-
graphic examination, sputum test for AFB, and physical
examination for further evaluation, respectively. For 171
patients who said “yes” for history of night sweating and
TB contact at the same time, 4(2.3%), 70(40.9%), and 97
(56.7%) were not linked to radiographic examination,
sputum test for AFB, and physical examination for addi-
tional evaluation of tuberculosis, respectively. About
14.3% of patients included in the chart review were not
screened for history of TB contact in the past year.
Correct diagnosis was done at the rate of 100% for
smear positive PTB, 23% for smear negative PTB and
87.8% for EPTB patients. In multivariate analysis history
of TB contact in the past 1 year (96.3% for smear posi-
tive PTB, 90.8% for smear negative PTB and 92.7% for
EPTB) and cough > 2 weeks were predictors of TB dis-
ease (Table 2).
Findings from the exit interview
A total of 309 respondents participated in the exit inter-
view. The mean age of the participants was 34 years
(range 18-55; SD = 6.4); 77.7% were aged < 39 years;
and 57% were females. 63.8% of respondents were sec-
ondary and above level of education and 30.4% of them
were unemployed. Over a half (52.1%) of the respon-
dents were co-infected with TB in the past 3 years after
they knew their HIV sero status of which 103(64.0%)
were taking CPT. Out of 162 co-infected patients 99
(61%) have a history of TB contact in the past 1 year.
From the multivariate analysis, history of TB contact in
the past year was a major predictor of TB disease (Table
3). About 46.6% of interview participants were not
screened for history of TB contact in the past year.
Discussion
This study uncovered high rates of HIV testing and
linkage to CPT among TB patients. This can likely be
attributed to the scaled up of PICT implementation in
the study setting and show commendable progress [10].
However, the low IPT uptake, incompleteness of TB
and PICT registers, and inadequate TB diagnostic capa-
city need more attention.
Although cough and history of TB contact in the past
year were found to be a major predictors for symptom
screening of tuberculosis in chart review (Table 2) and
Table 1 Baseline characteristics of the study participants
in Zewditu Memorial Hospital, Dec 2008
Characteristics Number
(%)
Gender
Female 125(51.9)
Male 116(48.1)
Age
18-30 156(64.7)
31-45 59(24.5)
46-80 26(10.8)
TB patients offered HIV testing
Yes 230(95.4)
No 11(4.6)
HIV test result
Positive 79(34.3)
Negative 123(53.5)
Not
indicated
28(12.2)
Post test counseling for those tested for
HIV
Yes 162(70.4)
No 23(10.0)
Not
indicated
45(19.6)
Referred sero-positives for HIV care
Within
facility
25(31.6)
Other facility 30(38.0)
Not
indicated
24(30.4)
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Figure 1 Profile of tuberculosis diagnosis abstracted from chart review, Zewditu Memorial Hospital, Ethiopia (January-December,
2008). Out of 238 HIV positive patients charts reviewed, 133 were co-infected with TB. Of these 27 were sputum positive pulmonary TB (PTB),
65 were sputum negative pulmonary TB [PTB (neg)], and 41 were extra pulmonary TB (EPTB). The diagnostic algorithm indicated correct
diagnosis were done for all PTB patients, 15 PTB (neg) patients and 36 EPTB patients. Among those diagnosed as PTB (neg), about 29 patients
had X-ray done that was suggestive of TB. One hundred and five patients were ruled out for tuberculosis but linkage to IPT was done only for
49(47%) patients. Linkage to CPT of TB/HIV co-infected patients was 80%.
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were not consistently used as TB screening criteria.
Poor adherence to the national guidelines in treating
smear negative PTB was discovered, with less than one
quarter of patients being diagnosed correctly. The same
was true for EPTB patients.
The World Health Organization (WHO) recommends
routine offering of HIV testing and CPT to all HIV
patients co-infected with TB. CPT is recommended to
all HIV positives co-infected with TB [3]. In a setting
with significant challenges HIV testing and CPT rates of
95 and 81% respectively concurs with these global
recommendations. Also, the HIV testing rate supersedes
that reported by neighboring Kenya [11]. The CPT
Uptake in our study setting exceeds that documented in
Uganda [12].
In concurrence with global reports (WHO 2010
report), the IPT uptake rate was low [13]. Although the
guidelines recommend IPT as part of the standard care
for HIV patients without active TB, low uptake con-
tinues to be challenge. This is not unique to Ethiopia.
Fear of isoniazid (INH) resistance, failure to exclude
active TB, poor adherence, shortage of supplies, and
provider attitudes appear to impede its scaled up imple-
mentation [14]. This highlights the need to continue to
advocate for improved delivery of IPT. More simplified
guidelines are now available to guide its strengthened
implementation [15]. Additional observed weaknesses of
the program such as failure to utilize symptom screen-
ing, poor adherence to national guidelines with regard
to treating smear negative PTB and EPTB can be
addressed through continuous education and mentoring
of health care providers.
Culture for Mycobacterium tuberculosis increases the
likelihood of diagnosis [16]. Nonetheless, due to costs of
sputum culture and FNA the proportion of patients bene-
fited from both tests was very low. About 56.5% people liv-
ing with HIV included in the study were unemployed and
hence unable to make payments for the indicated labora-
tory investigations. A recent prospective study evaluating
the prevalence of active TB in HIV infected patients with
a CD4 cell count of > 200 cells/μlr e p o r t e dt h a t2 9 %o f
those with culture- confirmed pulmonary TB had normal
radiography and clinical examination [17].
It appears that payments related with sputum culture
and FNA impede compliance with the national protocol
and the TB/HIV linkage activities in the study setting.
Exempting patients from payments associated with these
Table 2 Potential predictors of TB infection for chart review, Zewditu Memorial Hospital, Dec 2008.
Predictor variable Category Crude OR P-value* Adjusted OR P-value
Age 18-34 Referent 0.31 Referent
≥ 35 1.27
(0.76-2.11)
1.22
(0.71-2.07)
0.47
Occupation Unemployed Referent Referent
Employed 0.96
(0.74-1.26)
0.86 0.82
(0.48-1.42)
0.32
Education No education Referent Referent
Primary & above 0.77
(0.48-1.31)
0.26 1.62
(0.63-4.17)
0.32
History of TB contact No Referent Referent
Yes 3.06
(1.36-6.89)
0.007 2.81
(1.22-6.45)
0.02
Cough > 2 weeks No Referent Referent
Yes 3.79
(1.46-9.86)
0.006 3.77
(1.44-9.87)
0.01
*Level of significance at p < 0.05
Table 3 Analysis of TB contact as potential predictor to
TB disease for exit interview of PLHIV, Zewditu Memorial
Hospital, Dec 2008.
Predictor
variable
Category Crude
OR
P-
value*
Adjusted
OR
P-
value
TB contact No Referent Referent
Yes 1.93
(1.23-3.03)
0.004 2.76
(1.22-6.39)
0.006
Age 18-34 Referent Referent
≥ 35 0.94
(0.42-1.55)
0.81 1.04
(0.63-1.71)
0.87
Occupation Unemployed Referent Referent
Employed 0.89
(0.46-1.72)
0.61 1.095
(0.68-1.75)
0.71
Education No
education
Referent Referent
Primary &
above
0.76
(0.35-1.66)
0.492 1.13
(0.50-2.51)
0.77
* Level of significance at p < 0.05
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ing diagnostic problems. There is a need to strengthen
laboratories with better TB diagnostic facilities, primarily
for performing sputum culture and fluorescence micro-
scopy. This could be done by assisting the existing
laboratories in increasing the volume of testing and also
providing financial support for them to conduct targeted
tests such as sputum culture and FNA free of charge.
Adding sputum culture to the package of care for peo-
ple living with HIV (PLHIV) will substantially increase
case detection, which is part of Ethiopia’s commitment
to improve TB and HIV care.
Conclusion
The high rates of HIV testing and linkages to CPT are
encouraging indicators of progress in the implementa-
tion of TB/HIV collaborative activities in the study set-
ting. However, low rates of IPT, poor diagnostic
capacity, and inadequate documentation at TB clinics
need to be addressed. Structural barriers to TB diagnos-
tic facilities such as fees for TB culture need to be
solved, and simpler diagnostic techniques should be
made available in such settings. Periodic evaluation of
the progress using larger sample sizes among nationally
representative patient populations would contribute to
improved quality of care to TB/HIV co-infected patients
in Ethiopia.
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